Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome
- 1 August 2020
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 128, 101-106
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Losartan for Preventing Aortic Root Dilatation in Patients with Marfan Syndrome: A Meta-Analysis of Randomized TrialsCardiology and Therapy, 2019
- Causes of Mortality in the Marfan Syndrome(from a Nationwide Register Study)The American Journal of Cardiology, 2018
- FBN1: The disease-causing gene for Marfan syndrome and other genetic disordersGene, 2016
- 2014 ESC Guidelines on the diagnosis and treatment of aortic diseasesEuropean Heart Journal, 2014
- Angiotensin II Blockade and Aortic-Root Dilation in Marfan's SyndromeNew England Journal of Medicine, 2008
- Effect of Beta-Blockade on Ascending Aortic Dilatation in Children With the Marfan SyndromeThe American Journal of Cardiology, 2007
- Life expectancy in the Marfan syndromeThe American Journal of Cardiology, 1995
- Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndromeThe American Journal of Cardiology, 1994
- Progression of Aortic Dilatation and the Benefit of Long-Term β-Adrenergic Blockade in Marfan's SyndromeNew England Journal of Medicine, 1994
- β-Aminopropionitrile-induced dissecting aneurysms of turkeys: Treatment with propranololToxicology and Applied Pharmacology, 1970